|
| Press Releases |
|
 |
|
| Friday, January 10, 2020 |
|
|
SinoMab Granted the "Most Popular Newly Listed Company" Award |
| SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce that the Group has won the title of the "Most Popular Newly Listed Company" at the 4th Hong Kong Golden Stocks Awards held in Shenzhen. more info >> |
|
| Wednesday, November 20, 2019 |
|
|
类风湿关节炎治疗市场蓝海潜力巨大 中国抗体公布在研药物SM03类风湿关节炎III期临床试验最新进展 |
| 中国抗体制药有限公司（「中国抗体」或「公司」，连同其附属公司，统称「集团」；股份代号：3681.HK），专注研究、发展、制造及商业化免疫性疾病疗法的香港生物制药公司，欣然宣布其旗舰在研药物SM03类风湿关节炎III期临床试验最新进展。 more info >> |
|
|
類風濕關節炎治療市場藍海潛力巨大 中國抗體公佈在研藥物SM03類風濕關節炎III期臨床試驗最新進展 |
| 中國抗體製藥有限公司（「中國抗體」或「公司」,連同其附屬公司，統稱「集團」；股份代號：3681.HK），專注研究、發展、製造及商業化免疫性疾病療法的香港生物製藥公司，欣然宣佈其旗艦在研藥物SM03類風濕關節炎III期臨床試驗最新進展。 more info >> |
|
|
Great Potential in RA Therapeutic Market, Sinomab Announces Latest Progress of its Drug Candidate SM03 Phase III Clinical Trial for the Treatment RA |
| SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce its latest progress of SM03 phase III clinical trial for the treatment rheumatoid arthritis. more info >> |
|
| Monday, November 11, 2019 |
|
|
中国抗体（3681.HK）：商业化进程未来可期 |
| 2018年港交所设立新规，允许未盈利公司在香港主板上市，由此揭开了内地生物科技公司赴港上市热潮的序幕。 more info >> |
|
|
中國抗體（3681.HK）：商業化進程未來可期 |
| 2018年港交所設立新規，允許未盈利公司在香港主板上市，由此揭開了內地生物科技公司赴港上市熱潮的序幕。 more info >> |
|
| Wednesday, October 30, 2019 |
|
|
中国抗体制药宣布于港交所主板上市计划 |
| 中国抗体制药有限公司（「中国抗体制药」或「公司」连同其附属公司，统称「集团」；股份代号：3681.HK），专门研究、发展、制造及商业化免疫性疾病疗法且主要研制以单克隆抗体为基础的生物药的香港生物制药公司，今天宣布于香港联合交易所有限公司（「联交所」）主板上市计划。 more info >> |
|
|
中國抗體製藥宣佈於港交所主板上市計劃 |
| 中國抗體製藥有限公司（「中國抗體製藥」或「公司」連同其附屬公司，統稱「集團」；股份代號：3681.HK），專門研究、發展、製造及商業化免疫性疾病療法且主要研製以單克隆抗體為基礎的生物藥的香港生物製藥公司，今天宣佈於香港聯合交易所有限公司（「聯交所」）主板上市計劃。 more info >> |
|
|
SinoMab BioScience Announces Proposed Listing on the Main Board of SEHK |
| SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
TANAKA PRECIOUS METAL TECHNOLOGIES Develops AgSn TLP Sheet, a Sheet-type Bonding Material for Power Semiconductors
Jan 23, 2025 11:00: JST
|
|
|
日本総合研究所と富士通が、三井住友銀行のシステムバージョンアップに生成AIを用いた共同実証で生産性向上を実現
Jan 23, 2025 10:15: JST
|
|
|
田中贵金属工业开发了面向功率半导体的片状接合材料“AgSn TLP片”
Jan 23, 2025 10:00 HKT/SGT
|
|
|
ZeroPath 公司推出下一代代碼安全平台，結合人工智慧技術
Jan 23, 2025 10:00 HKT/SGT
|
|
|
ZeroPath Corp. Launches Next-Generation Code Security Platform Powered by Artificial Intelligence
Jan 23, 2025 10:00 HKT/SGT
|
|
|
다나까귀금속공업, 전력반도체용 시트형상 접합 재료 ‘AgSn TLP 시트’ 개발
Jan 23, 2025 10:00 HKT/SGT
|
|
|
田中貴金屬工業開發出適用於功率半導體的片狀接合材料「AgSn TLP片」
Jan 23, 2025 10:00 HKT/SGT
|
|
|
田中贵金属工业开发了面向功率半导体的片状接合材料“AgSn TLP片”
Jan 23, 2025 10:00 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES Develops AgSn TLP Sheet, a Sheet-type Bonding Material for Power Semiconductors
Jan 23, 2025 11:00 JST
|
|
|
Tamkeen Launches 'Bahrain Skills and Gender Parity Accelerator' at Davos
Jan 23, 2025 08:00 HKT/SGT
|
|
|
The Now Corporation (OTC:NWPN) Subsidiary, Green Rain Solar Inc., Explores Selling Development Rights for Solar Farm Project in Greece, NY
Jan 22, 2025 21:00 HKT/SGT
|
|
|
The Now Corporation (OTC:NWPN) 旗下子公司 Green Rain Solar Inc. 探討在紐約州希臘鎮出售太陽能農場開發權
Jan 22, 2025 21:00 HKT/SGT
|
|
|
MHI Receives Order for 3 New Series Trainsets (12 Cars) for Seibu Railway's Yamaguchi Line
Jan 22, 2025 17:27 JST
|
|
|
Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company
Jan 22, 2025 17:18 JST
|
|
|
2nd Annual Operational Excellence & Business Transformation Summit: Operational Excellence in The Age of Digital Transformation, Building A Sustainable and Collaborative Future in Asia
Jan 22, 2025 16:15 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
